Danqi Pill regulates lipid metabolism disorder induced by myocardial ischemia through FATP-CPTI pathway

Table 1 Cardiac function-related parameters in different groups \( \left(\overline{x}\pm \mathrm{s}\right) \)

Group	N	Sham	Model	Danqi pill	Positive drug
LV Mass (ug)	12	647.29 ± 206.658^**	936.29 ± 203.356	803.33 ± 213.294	872.65 ± 137.586
IVS;d (cm)	12	1.986 ± 0.316^**	1.402 ± 0.378	1.532 ± 0.500	1.190 ± 0.380
IVS;s(cm)	12	2.915 ± 0.592 ^**	1.658 ± 0.684	2.050 ± 0.886	1.476 ± 0.539
LVEDd(cm)	12	5.735 ± 0.656^**	8.741 ± 1.2054	7.777 ± 1.869	9.107 ± 1.138
LVED;s(cm)	12	2.988 ± 0.829 ^**	7.059 ± 1.535	5.746 ± 2.502^*	7.538 ± 1.519
LVPWd(mm)	12	2.030 ± 0.441^**	2.012 ± 0.389	1.953 ± 0.392	1.852 ± 0.361
LVPWs(mm)	12	2.758 ± 0.598^**	2.792 ± 0.481	2.254 ± 0.618	2.560 ± 0.618
EF (%)	12	78.274 ± 10.514^**	41.388 ± 17.238	52.375 ± 24.421^**	34.823 ± 14.849
FS(%)	12	48.826 ± 10.557^**	21.882 ± 10.552	30.241 ± 17.328^**	17.905 ± 8.367

^*P < 0.05, ^**P < 0.01, Levels in the model group were used as reference to calculate P values.